Biosense Webster, Inc.

This study is checking the long-term safety and effectiveness of an FDA-approved catheter system for treating irregular heartbeats. It involves 276 people with symptomatic atrial fibrillation who haven't responded well to medication. The research focuses on whether the treatment …

This study is collecting real-world safety and performance data on already-approved medical devices used to treat irregular heartbeats. It will follow 8,000 patients who are scheduled to have a standard heart rhythm procedure. The goal is to confirm the devices work safely in eve…

This study is testing a new pulsed field ablation system to treat people with symptomatic paroxysmal atrial fibrillation, a type of irregular heartbeat. The procedure aims to isolate problematic heart veins to prevent abnormal rhythms. Researchers will enroll 440 participants to …

This study is testing a new paddle-shaped catheter designed to create detailed maps of irregular heartbeats. The device will be used in 60 patients with conditions like atrial fibrillation and ventricular tachycardia who are already scheduled for a heart procedure. Researchers wa…